Towards full qualification of CT1 and pdff as enrichment biomarkers for drug development: characterising performance in the target population
Ended Cooperative Agreement Awarded Last action
- Award ID
- U01FD006880
- Recipient
-
Perspectum, Inc. UEI N9MKJG4DMFB5
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $249,940
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date
- Originally
- Funding agency
- Center for Drug Evaluation and Research Food and Drug Administration, Department of Health and Human Services
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $249,940 |
Quick answers
Who received award U01FD006880?
U01FD006880 was awarded to Perspectum, Inc. by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 1, 2019.
How much is award U01FD006880 worth?
$249,940 has been obligated on U01FD006880.
Which agency awarded U01FD006880?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U01FD006880, with funding from Center for Drug Evaluation and Research (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award